TrialJAMA network open2020

Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial.

Lu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.